irbesartan bms
bristol-myers squibb pharma eeig - irbesartaania - verenpainetauti - reniini-angiotensiinijärjestelmään vaikuttavat aineet - essentiaalisen hypertension hoito. munuaistaudin hoito potilailla, joilla on korkea verenpaine ja tyypin 2 diabetes osana verenpainelääkityksen (ks. kohta 5.
budenofalk 9 mg enterorakeet
dr. falk pharma gmbh - budesonide - enterorakeet - 9 mg - budesonidi
degarelix accord
accord healthcare s.l.u. - degarelix acetate - prostatiset kasvaimet - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
firmagon
ferring pharmaceuticals a/s - degareliksia - prostatiset kasvaimet - endokriinihoito - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
budenofalk 3 mg enterokapseli, kova
dr. falk pharma gmbh - budesonide - enterokapseli, kova - 3 mg - budesonidi
dutasteride/tamsulosinhydrochloride hexal 0.5 mg / 0.4 mg kapseli, kova
hexal a/s - tamsulosini hydrochloridum,dutasteridum - kapseli, kova - 0.5 mg / 0.4 mg - tamsulosiini ja dutasteridi
estracyt 140 mg kapseli, kova
pfizer oy pfizer oy - estramustini natrii phosphas monohydricus - kapseli, kova - 140 mg - estramustiini
enanton depot set 11.25 mg injektiokuiva-aine ja liuotin, suspensiota varten
orion corporation - leuprorelini acetas - injektiokuiva-aine ja liuotin, suspensiota varten - 11.25 mg - leuproreliini